BUYINS.NET

Email Address / User Name:
Password:





	REGISTER HERE Why Register? SqueezeTrigger Info Naked Short Exposed Naked Short Update Naked Short Proof Phantom Shares TV commercial Cramer on Shorts No Short List New Short Rules New Reg SHO SEC Enforces SHO New UpTick Rule



Services
	SqueezeTrigger Data Naked Short Data SqueezeTrigger Alerts! SqueezeTrigger Reports SqueezeTrigger Portfolio



Naked Short List

	New to List Buyin Imminent Off List Today Trade Signals Performance

	by date
	2013-05-20 2013-05-17 2013-05-16 2013-05-15 2013-05-14 2013-05-13 2013-05-10 2013-05-09 2013-05-08 2013-05-07 2013-05-06 2013-05-03 2013-05-02 2013-05-01 2013-04-30 2013-04-29 2013-04-26 2013-04-25 2013-04-24 2013-04-23

	by exchange
	NASDAQ AMEX NYSE



Press Releases
	Naked Short News SqueezeTrigger News Friction Factor News All Releases



Articles
	Bloomberg Article NY Post Article New Buyin Rule Naked Short Article Naked Short Survey Naked Shorts Beware RegSHO Amendment RegSHO Updated RegSHO Legal Study



	Contact Us About Us

Current Quote^*

Last:	$3.110
Volume:	139,600
As Of: 2013-05-21 20:27:59 ET *Quotes delayed by 20min.

Transcept Pharmaceuticals Inc (NASDAQ:TSPT)
Industry: Healthcare

Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience. Its principal product is the Intermezzo, a low dose sublingual formulation of zolpidem as a sleep aid for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. The company has a collaboration agreement with Purdue Pharmaceutical Products, L.P. for the commercialization of Intermezzo in the United States. It is also developing TO-2061, a low dose ondansetron adjunctive therapy, which is in Phase II study for patients with obsessive-compulsive disorder. The company was founded in 2002 and is based in Point Richmond, California.

Realtime Data

BuyIns.Net Releases for Symbol TSPT

[05/17/2013 06:20 PDT] TSPT, Biomed and Genetics Stocks Undervalued
[05/17/2013 03:07 PDT] TSPT Are Seasonally Ripe To Go Up In the Next Five Weeks
[05/15/2013 07:16 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Up By 5.30% ($0.17) From $3.229 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
[05/14/2013 05:52 PDT] TSPT Expected to Trade Up After Bullish Patterns Develop
[04/19/2013 03:40 PDT] TSPT Are Seasonally Ripe To Go Up In the Next Five Weeks
[03/22/2013 03:09 PDT] TSPT Are Seasonally Ripe To Go Up In the Next Five Weeks
[03/19/2013 07:40 PDT] TSPT Expected to Trade Down Short Term
[03/12/2013 05:48 PDT] TSPT Expected to Trade Down Short Term
[02/19/2013 01:14 PST] TSPT Are Seasonally Ripe To Go Down In the Next Five Weeks
[01/29/2013 06:39 PST] TSPT Expected to Trade Up Short Term
[01/15/2013 03:12 PST] TSPT Are Seasonally Ripe To Go Down In the Next Five Weeks
[12/14/2012 01:42 PST] TSPT Are Seasonally Ripe To Go Up In the Next Five Weeks
[11/27/2012 17:45 PST] Market Maker Surveillance Report. TSPT, Winning Stocks With Lowest Price Friction For Tuesday, November 27th 2012
[11/26/2012 06:01 PST] TSPT Expected to Trade Down After Bearish Patterns Develop
[11/20/2012 06:40 PST] TSPT Expected to Trade Down After Bearish Patterns Develop
[11/16/2012 07:07 PST] TSPT Expected to Trade Down After Bearish Patterns Develop
[11/16/2012 02:09 PST] TSPT Are Seasonally Ripe To Go Up In the Next Five Weeks
[11/15/2012 08:11 PST] TSPT Expected to Trade Down After Bearish Patterns Develop
[11/14/2012 08:20 PST] TSPT Expected to Trade Down After Bearish Patterns Develop
[11/14/2012 07:16 PST] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Up By 13.80% ($0.57) From $4.130 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
[11/13/2012 08:24 PST] TSPT Expected to Trade Up After Bullish Patterns Develop
[11/12/2012 06:25 PST] TSPT Expected to Trade Up After Bullish Patterns Develop
[11/09/2012 07:09 PST] TSPT Expected to Trade Up After Bullish Patterns Develop
[11/08/2012 06:49 PST] TSPT Expected to Trade Up After Bullish Patterns Develop
[11/06/2012 05:44 PST] TSPT Expected to Trade Up After Bullish Patterns Develop
[10/22/2012 07:16 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 6.78% ($0.36) From $5.310 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
[10/19/2012 06:09 PDT] TSPT Expected to Trade Down Short Term
[10/19/2012 05:35 PDT] TSPT Are Seasonally Ripe To Go Up In the Next Five Weeks
[09/21/2012 02:41 PDT] TSPT Are Seasonally Ripe To Go Down In the Next Five Weeks
[09/19/2012 06:40 PDT] TSPT Expected to Trade Down Short Term
[09/17/2012 06:32 PDT] TSPT Expected to Trade Down Short Term
[08/15/2012 08:29 PDT] TSPT Expected to Trade Down Short Term
[08/15/2012 04:02 PDT] TSPT Are Seasonally Ripe To Go Down In the Next Five Weeks
[08/07/2012 05:54 PDT] TSPT Expected to Trade Up After Bullish Patterns Develop
[07/31/2012 06:32 PDT] TSPT Expected to Trade Down Short Term
[06/19/2012 04:08 PDT] TSPT Are Seasonally Ripe To Go Down In the Next Five Weeks
[05/21/2012 07:16 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 22.35% ($1.94) From $8.680 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
[05/21/2012 04:22 PDT] TSPT Are Seasonally Ripe To Go Up In the Next Five Weeks
[05/16/2012 11:16 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 8.18% ($0.71) From $8.680 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
[05/09/2012 05:50 PDT] TSPT Expected to Trade Down Short Term
[04/30/2012 06:00 PDT] TSPT, Removed From Naked Short Lists Today
[04/23/2012 06:12 PDT] TSPT Are Seasonally Ripe To Go Up In the Next Five Weeks
[04/20/2012 06:00 PDT] TSPT, Added To Naked Short Lists Today
[03/22/2012 06:23 PDT] TSPT Are Seasonally Ripe To Go Up In the Next Five Weeks
[03/19/2012 07:16 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Up By 16.90% ($1.42) From $8.400 After BUYINS.NET Report Predicted Strength After Earnings
[03/15/2012 13:16 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Up By 5.12% ($0.43) From $8.400 After BUYINS.NET Report Predicted Strength After Earnings
[03/13/2012 03:07 PDT] TSPT Expected To Be Up After Next Earnings Releases
[03/02/2012 13:16 PST] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 5.75% ($0.49) From $8.520 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
[02/22/2012 01:22 PST] TSPT Are Seasonally Ripe To Go Down In the Next Five Weeks
[01/25/2012 03:25 PST] TSPT Are Seasonally Ripe To Go Down In the Next Five Weeks
[01/11/2012 09:16 PST] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Up By 8.34% ($0.65) From $7.790 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
[12/27/2011 04:03 PST] TSPT Are Seasonally Ripe To Go Up In the Next Five Weeks
[12/14/2011 07:23 PST] TSPT Expected to Trade Down Short Term
[12/02/2011 06:46 PST] TSPT Expected to Trade Up Short Term
[12/01/2011 05:16 PST] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Up By 28.57% ($2.00) From $7.000 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
[11/28/2011 03:52 PST] TSPT Are Seasonally Ripe To Go Up In the Next Five Weeks
[11/22/2011 07:16 PST] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Up By 13.55% ($0.90) After BUYINS.NET SqueezeTrigger Report Released on Friday, November 18th 2011 at a Price of $6.649.
[11/21/2011 11:17 PST] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Up By 7.08% ($0.47) After BUYINS.NET SqueezeTrigger Report Released on Friday, November 18th 2011 at a Price of $6.649.
[11/18/2011 11:16 PST] TSPT SqueezeTrigger Price is $6.65. There is $4,530,931 That Short Sellers Still Need To Cover.
[11/09/2011 06:01 PST] TSPT Expected To Be Up After Next Earnings Releases
[11/04/2011 04:29 PDT] TSPT Expected To Be Down Before Next Earnings Releases
[10/26/2011 05:16 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 7.78% ($0.63) From $8.100 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
[10/25/2011 03:12 PDT] TSPT Are Seasonally Ripe To Go Down In the Next Five Weeks
[10/21/2011 06:41 PDT] TSPT, Biomed - Genetics Stocks Undervalued
[10/04/2011 17:45 PDT] Market Maker Surveillance Report. TSPT, Winning Stocks With Lowest Price Friction For Tuesday, October 4th 2011
[09/26/2011 08:47 PDT] TSPT Are Seasonally Ripe To Go Down In the Next Five Weeks
[09/20/2011 17:45 PDT] Market Maker Surveillance Report. TSPT, Winning Stocks With Lowest Price Friction For Tuesday, September 20th 2011
[09/15/2011 17:45 PDT] Market Maker Surveillance Report. TSPT, Winning Stocks With Lowest Price Friction For Thursday, September 15th 2011
[09/14/2011 17:45 PDT] Market Maker Surveillance Report. TSPT, Winning Stocks With Lowest Price Friction For Wednesday, September 14th 2011
[08/19/2011 13:15 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 11.96% ($0.36) From $3.010 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
[08/19/2011 13:15 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 5.69% ($0.16) From $2.810 After BUYINS.NET Report Predicted Weakness After Earnings
[08/18/2011 09:16 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 6.31% ($0.19) From $3.010 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
[08/13/2011 19:55 PDT] TSPT Are Seasonally Ripe To Go Down In the Next Five Weeks
[08/12/2011 11:12 PDT] TSPT Are Seasonally Ripe To Go Down In the Next Five Weeks
[08/10/2011 07:16 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 73.29% ($7.49) From $10.220 After BUYINS.NET Report Predicted Weakness After Earnings
[08/10/2011 06:01 PDT] TSPT Expected To Be Down After Next Earnings Releases
[08/09/2011 05:16 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 26.08% ($0.97) From $3.720 After BUYINS.NET Report Predicted Weakness Before Earnings
[08/08/2011 11:15 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 18.82% ($0.70) From $3.720 After BUYINS.NET Report Predicted Weakness Before Earnings
[08/05/2011 05:15 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 12.63% ($0.47) From $3.720 After BUYINS.NET Report Predicted Weakness Before Earnings
[08/04/2011 05:15 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 6.18% ($0.23) From $3.720 After BUYINS.NET Report Predicted Weakness Before Earnings
[08/03/2011 06:36 PDT] TSPT Expected To Be Down Before Next Earnings Releases
[07/15/2011 05:16 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 54.60% ($5.58) From $10.220 After BUYINS.NET Report Predicted Weakness After Earnings
[07/14/2011 05:16 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 52.15% ($5.33) From $10.220 After BUYINS.NET Report Predicted Weakness After Earnings
[07/13/2011 17:45 PDT] Market Maker Surveillance Report. TSPT, Losing Stocks With Lowest Price Friction For Wednesday, July 13th 2011
[07/12/2011 05:16 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 24.27% ($2.48) From $10.220 After BUYINS.NET Report Predicted Weakness After Earnings
[07/08/2011 17:45 PDT] Market Maker Surveillance Report. TSPT, Losing Stocks With Lowest Price Friction For Friday, July 8th 2011
[07/08/2011 05:15 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 16.34% ($1.67) From $10.220 After BUYINS.NET Report Predicted Weakness After Earnings
[06/09/2011 05:16 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Down By 5.97% ($0.61) From $10.220 After BUYINS.NET Report Predicted Weakness After Earnings
[05/13/2011 06:18 PDT] TSPT Expected To Be Down After Next Earnings Releases
[05/11/2011 05:16 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Up By 23.73% ($1.96) After BUYINS.NET SqueezeTrigger Report Released on Monday, March 21st 2011 at a Price of $8.252.
[05/10/2011 06:13 PDT] TSPT Expected To Be Down Before Next Earnings Releases
[05/05/2011 05:47 PDT] TSPT Expected To Be Down Before Next Earnings Releases
[04/06/2011 00:00 PDT] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Up By 7.97% ($0.66) After BUYINS.NET SqueezeTrigger Report Released on Monday, March 21st 2011 at a Price of $8.252.
[03/21/2011 13:16 PDT] TSPT SqueezeTrigger Price is $8.25. There is $1,117,180 That Short Sellers Still Need To Cover.
[03/04/2011 08:00 PST] Transcept Pharmaceuticals Inc (NASDAQ:TSPT), Up By 7.35% ($0.65) From $8.840 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
[01/26/2011 12:14 PST] TSPT, Biomed - Genetics Stocks Undervalued

3 Month

6 Month

1 Year